Fernanda Palhano-Fontes

Fernanda Palhano-Fontes

Auto-generated profile, based on publicly available information

Fernanda Palhano-Fontes

Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
MFMarcelo Falchi-Carvalho
Marcelo Falchi-Carvalho
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
IWIsabel Wießner
Isabel Wießner
HBHandersson Barros
Handersson Barros
RBRaynara Bolcont
Raynara Bolcont
DADraulio B. Araujo
Draulio B. Araujo

13 July 2021 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
IWIsabel Wießner
Isabel Wießner
MFMarcelo Falchi
Marcelo Falchi
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
AFAmanda Feilding
Amanda Feilding
SRSidarta Ribeiro
Sidarta Ribeiro
LTLuís Fernando Tófoli
Luís Fernando Tófoli
Background: For a century, psychedelics have been investigated as models of psychosis for demonstrating phenomenological similarities with psychotic experiences and as therapeutic models for treating depression, anxiety, and substance use disorders. This study sought to explore this paradoxical relationship connecting key parameters of the psychotic experience, psychotherapy, and psychedelic experience.Methods: In a randomized, double-blind, placebo-controlled, crossover design, 24 healthy volunteers received 50 μg d-lysergic acid diethylamide (LSD) or inactive placebo. Psychotic experience was assessed by aberrant salience (Aberrant Salience Inventory, ASI), therapeutic potential by suggestibility (Creative Imagination Scale, CIS) and mindfulness (Five Facet Mindfulness Questionnaire, FFMQ; Mindful Attention Awareness Scale, MAAS; Experiences Questionnaire, EQ), and psychedelic experience by four questionnaires (Altered State of Consciousness Questionnaire, ASC; Mystical Experiences Questionnaire, MEQ; Challenging Experiences Questionnaire, CEQ; Ego-Dissolution Inventory, EDI). Relationships between LSD-induced effects were examined.Results: LSD induced psychedelic experiences, including alteration of consciousness, mystical experiences, ego-dissolution, and mildly challenging experiences, increased aberrant salience and suggestibility, but not mindfulness. LSD-induced aberrant salience correlated highly with complex imagery, mystical experiences, and ego-dissolution. LSD-induced suggestibility correlated with no other effects. Individual mindfulness changes correlated with aspects of aberrant salience and psychedelic experience.Conclusions: The LSD state resembles a psychotic experience and offers a tool for healing. The link between psychosis model and therapeutic model seems to lie in mystical experiences. The results point to the importance of meaning attribution for the LSD psychosis model and indicate that psychedelic-assisted therapy might benefit from therapeutic suggestions fostering mystical experiences.

11 February 2022 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
IWIsabel Wießner
Isabel Wießner
RORodolfo Olivieri
Rodolfo Olivieri
MFMarcelo Falchi
Marcelo Falchi
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
LMLucas Oliveira Maia
Lucas Oliveira Maia
LTLuís Fernando Tófoli
Luís Fernando Tófoli

30 January 2019 in Entropy
Verified
Journal Article
Open access
PDF file
AVAline Viol
Aline Viol
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
HOHeloisa Onias
Heloisa Onias
DADraulio B. de Araujo
Draulio B. de Araujo
PHPhilipp Hövel
Philipp Hövel
Gandhimohan M. ViswanathanGandhimohan M. Viswanathan
Gandhimohan M. Viswanathan
With the aim of further advancing the understanding of the human brain’s functional connectivity, we propose a network metric which we term the geodesic entropy. This metric quantifies the Shannon entropy of the distance distribution to a specific node from all other nodes. It allows to characterize the influence exerted on a specific node considering statistics of the overall network structure. The measurement and characterization of this structural information has the potential to greatly improve our understanding of sustained activity and other emergent behaviors in networks. We apply this method to study how the psychedelic infusion Ayahuasca affects the functional connectivity of the human brain in resting state. We show that the geodesic entropy is able to differentiate functional networks of the human brain associated with two different states of consciousness in the awaking resting state: (i) the ordinary state and (ii) a state altered by ingestion of the Ayahuasca. The functional brain networks from subjects in the altered state have, on average, a larger geodesic entropy compared to the ordinary state. Finally, we discuss why the geodesic entropy may bring even further valuable insights into the study of the human brain and other empirical networks.

6 April 2026 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MGManesh Girn
Manesh Girn
MDManoj K. Doss
Manoj K. Doss
LRLeor Roseman
Leor Roseman
KPKatrin H. Preller
Katrin H. Preller
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
DBDanilo Bzdok
Danilo Bzdok
Psychedelic drugs are re-emerging as promising scientific and clinical tools. However, despite a rapidly expanding literature on their therapeutic value, the neural mechanisms underlying psychedelic effects remain unclear. Resting-state functional magnetic resonance imaging studies of acute psychedelic effects, conducted independently by several research groups, have so far yielded fragmented and sometimes inconsistent findings. Here, to help facilitate greater convergence, we conducted a ‘mega-analysis’ integrating 11 independent resting-state functional magnetic resonance imaging datasets across five psychedelic drugs (psilocybin, lysergic acid diethylamide, mescaline, N,N-dimethyltryptamine and ayahuasca) from research groups spanning three continents and five countries. By applying a uniform preprocessing pipeline and a Bayesian hierarchical modeling framework, we discovered several common features in the induced alterations to brain function across drugs and sites. Most prominently, we identified a core signature of increased functional connectivity between transmodal (default, frontoparietal and limbic) and unimodal networks (visual and somatomotor), with subnetwork specificity. Furthermore, key subcortical regions (thalamus, caudate and putamen) and the cerebellum exhibited altered coupling with sensorimotor networks. In contrast to several single-site reports, Bayesian modeling revealed weak-to-moderate and selective reductions in within-network functional connectivity, with substantial variability across drugs and networks. Together, these findings extend past work by demonstrating that psychedelics reconfigure large-scale cortical organization while selectively engaging subcortical circuitry. This study provides the most comprehensive synthesis of psychedelic brain action to date, helping resolve inconsistencies and offering a probabilistic map of how psychedelics alter large-scale brain organization. We hereby provide a cornerstone to benchmark and shepherd future psychedelic neuroimaging research.

22 December 2023 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
MFMarcelo Falchi-Carvalho
Marcelo Falchi-Carvalho
IWIsabel Wießner
Isabel Wießner
SSSérgio Ruschi Bergamachi Silva
Sérgio Ruschi Bergamachi Silva
LMLucas O. Maia
Lucas O. Maia
HBHandersson Barros
Handersson Barros
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes